Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DBD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,155
Award facts
- Contract value 100% obligated
- $17,154.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,154.88 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on January 12, 2026, with completion anticipated by January 13, 2026. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare systems globally.
Dupixent (dupilumab) is a specialty biologic medication prescribed for conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. The delivery order reflects AmerisourceBergen's critical role as a major pharmaceutical distributor within the federal medical supply chain, particularly for military and veteran healthcare systems. The non-competitive nature of this award as a task order under the existing IDC demonstrates the company's established capability to fulfill government pharmaceutical procurement requirements through established contract vehicles designed to provide flexible and comprehensive medical commodity support across the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26F9DBD?
SPE2DR26F9DBD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9DBD worth?
The government has obligated $17,155 on SPE2DR26F9DBD.
Is contract SPE2DR26F9DBD an order under another contract?
Yes. SPE2DR26F9DBD is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DBD competed?
The extent of competition for SPE2DR26F9DBD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award